VIRI Virios Therapeutics Inc. Net earnings per share growth forecast for next year

Virios Therapeutics Inc. (VIRI) - corporate logo

The projected change in earnings per share for Virios Therapeutics (VIRI) for the coming year demonstrates volatility due to liquidity shortages and platform merger complexities. This price action reflects the metric value at 18.20. The business relies on outsourcing drug development to third-party organizations, which reduces costs. Simultaneously, Virios Therapeutics (VIRI) is developing scientific alliances for the therapy of chronic pain and fibromyalgia.

VIRI - Virios Therapeutics Inc. Net earnings per share growth forecast for next year over the range 07/04/2022 - 10/09/2024

Virios Therapeutics Inc. - analytical breakdowns and key metrics (VIRI)

- stock quotes and analyst forecast:
Initial company analysis:VIRI, Virios Therapeutics
Core merchandise of Virios Therapeutics, Inc.

This indicator reflects the dynamics of discounting future cash flows under the Federal Reserve's tight monetary policy, measuring the sensitivity of net yield to the cost of capital. By analyzing the expected EPS trajectory over the next 12 months, investors can decouple the fundamental potential of Virios Therapeutics (VIRI) from market noise, assessing the viability of its fibromyalgia drug development amidst pressure from biotech behemoths.

Competitors of Virios Therapeutics

Expected earnings per share growth for next year GILD|Earnings growth forecast for next year Cidara Therapeutics, Inc.|Net earnings per share growth forecast for next year Novavax Inc (NVAX)|Consensus forecast of earnings per share growth for next year CureVac|Valneva Pharma - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Vir Corp (VIR)|siga.com - Earnings growth forecast for next year|Expected net earnings per share growth next year emergentbiosolutions.com|AVIR: Earnings growth forecast for next year|IVVD (Invivyd Inc) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year Enanta Pharmaceuticals|Inovio Pharma (INO) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year HLVX|KLRS (Kalaris Therapeutics Inc) - Expected earnings per share trend next year|Earnings growth forecast for next year DYAI (Dyadic International)|Consensus forecast of earnings per share growth for next year NanoViricides, Inc. (NNVC)|TLPH - Net earnings per share growth forecast for next year|Cocrystal - Projected earnings per share increase next year|TRAW: Earnings growth forecast for next year|Dogwood Therapeutics, Inc. - Expected earnings per share trend next year|Expected earnings per share growth for next year QLGN|allovir.com (ALVR) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year VBI Vaccines Inc (VBIV)|Expected earnings per share growth for next year Vaxart Corp VXRT